Health Care · Services-Medical Laboratories · Nasdaq · CIK 1635077 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $2.02Day −5.40%Mkt cap $5M1Y −73.8%Off 52W high −83.3%Vol (1Y) 93.6%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,065 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest1.7% of sh out |
| Days to cover1.3d |
| 13F net flow (QoQ)+0.53% |
| Top-10 13F concentration100.0% |
| Next report (est.)2026-08-12 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$77,879 |
| Earnings (TTM)-$8.0M |
| ROE−104.8% |
| Net margin−9551.9% |
| ROIC−834.2% |
| Sales growth 3Y7.8% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−56.2% |
| 1Y−73.8% |
| 3Y−100.0% |
| Since incept. (ann.)−94.2% |
Total return through 2026-07-29 · series begins 2022-04-22. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)93.6% |
| Ann. volatility (3Y)159.5% |
| Sharpe (1Y)−0.98 |
| Sharpe (3Y)−1.38 |
| Max drawdown (1Y)−79.2% |
| Max drawdown (3Y)−100.0% |
| Beta (3Y vs SPY)1.38 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| OSAIC HOLDINGS, INC. | 34,945 | $114,269 | 1.42% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 31,215 | $102,072 | 1.27% | new |
| CAPTRUST FINANCIAL ADVISORS | 14,559 | $47,608 | 0.59% | +45.6% |
| BANK OF MONTREAL /CAN/ | 10,000 | $32,700 | 0.41% | new |
| UBS Group AG | 9,647 | $31,546 | 0.39% | +818.8% |
| VANGUARD CAPITAL MANAGEMENT LLC | 6,782 | $22,177 | 0.28% | new |
| Dauntless Investment Group, LLC | 5,422 | $17,730 | 0.22% | +0.0% |
| Clear Street Group Inc. | 3 | $10 | 0.00% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-13 | −$1.34 | — | $21,140 | +11.3% |
| 2025-12-31 | 2026-03-18 | — | — | $18,478 | +80.6% |
| 2025-09-30 | 2025-11-12 | −$2.93 | — | $18,942 | +31.5% |
| 2025-06-30 | 2025-08-14 | −$2.75 | — | $19,319 | +76.1% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-12 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
